CYTOKINETICS INC (CYTK) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CYTK currently has 124M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 5.64% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 05, 2026 |
10-Q filing | 124.4M shares outstanding |
120M | 0 |
| Nov 05, 2025 |
10-Q filing | 122.3M shares outstanding |
120M | 0 |
| May 06, 2025 |
10-Q filing | 119.4M shares outstanding |
120M | 0 |
| Feb 27, 2025 |
10-K filing | 118.4M shares outstanding |
120M | 0 |
| Nov 07, 2024 |
10-Q filing | 118.0M shares outstanding |
120M | 0 |
| Aug 09, 2024 |
10-Q filing | 117.7M shares outstanding |
120M | 0 |
| May 10, 2024 |
10-Q filing | 104.9M shares outstanding |
100M | 0 |
| Feb 28, 2024 |
10-K filing | 103.0M shares outstanding |
100M | 0 |
| Nov 03, 2023 |
10-Q filing | 98.1M shares outstanding |
98M | 0 |
| Aug 03, 2023 |
10-Q filing | 96.0M shares outstanding |
96M | 0 |
| May 05, 2023 |
10-Q filing | 95.6M shares outstanding |
96M | 0 |
| Mar 01, 2023 |
10-K filing | 95.2M shares outstanding |
95M | 0 |
| Nov 04, 2022 |
10-Q filing | 94.6M shares outstanding |
95M | 0 |
| Aug 05, 2022 |
10-Q filing | 94.1M shares outstanding |
94M | 0 |
| May 06, 2022 |
10-Q filing | 85.7M shares outstanding |
86M | 0 |
| Feb 25, 2022 |
10-K filing | 84.9M shares outstanding |
85M | 0 |
| Dec 20, 2021 |
8-K filing: Cytokinetics entered into a License and Collaboration Agreement with Ji Xing Pharmaceuticals Limited, granting Ji Xing an exclusive license to develop and commercialize Cytokinetics' proprietary small molecule cardiac sarcomere activator known as omecamtiv mecarbil in the greater China region and also entered into Common Stock Purchase Agreements with RTW Investors for the sale and issuance of 511,182 shares of Cytokinetics common stock at $39.125 per share. ($20.0M proceeds) |
84M | 0 |
| Nov 05, 2021 |
10-Q filing | 83.9M shares outstanding |
84M | 0 |
| Aug 06, 2021 |
10-Q filing | 83.5M shares outstanding |
84M | 0 |
| May 07, 2021 |
10-Q filing | 71.7M shares outstanding |
72M | 0 |
| Feb 26, 2021 |
10-K filing | 71.1M shares outstanding |
71M | 0 |
| Nov 06, 2020 |
10-Q filing | 70.8M shares outstanding |
71M | 0 |
| Aug 07, 2020 |
10-Q filing | 70.5M shares outstanding |
71M | 0 |
| May 08, 2020 |
10-Q filing | 59.5M shares outstanding |
59M | 0 |
| Mar 04, 2020 |
10-K filing | 59.5M shares outstanding |
59M | 0 |